Germany Veterinary Healthcare Market Size (2024 - 2029)

Germany Veterinary Healthcare Market Analysis

The Germany Veterinary Healthcare Market size is estimated at USD 3.48 billion in 2024, and is expected to reach USD 4.34 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

The COVID-19 pandemic impacted the veterinary healthcare market by increasing the costs of animal testing and veterinary care. Supply chain disruptions and shortages of veterinary medicines were observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine for the treatment of COVID-19. For instance, according to an article published in February 2021, the demand for veterinary services and visits to pet clinics reduced in the country during the COVID-19 pandemic, impacting the growth of the veterinary healthcare market. Furthermore, according to a Health for Animals article, the World Veterinary Association (WVA) and regional veterinary organizations in Europe declared veterinary services to be essential in 2020, just like human healthcare services. As a result, a large number of veterinarians worked under the COVID-19 circumstances. The European Medicines Agency (EMA) created and implemented a few standards to guarantee the accessibility of veterinary medications on the German market. However, with pet clinic services resuming and the relaxation of COVID-19 restrictions, the German veterinary healthcare market is expected to grow over the forecast period.

According to Der Deutsche Heimtiermarkt, 47% of the households in Germany had pets in 2021. In addition, 34.7 million dogs, cats, small animals, and ornamental birds were kept by the population in the country. In Germany, laws and the veterinary administration work together to safeguard animal health. They guarantee good animal husbandry and cleanliness and efficient disease prevention and eradication efforts. It also confirms whether or not animals are given effective, authorized veterinary medicines. Therefore, it is projected that such occurrences will favor market growth in Germany throughout the forecast period.

The strategic initiatives adopted by key market players, such as product approvals, launches, partnerships, and acquisitions, are fueling the market growth. For instance, in July 2021, Boehringer Ingelheim revealed that the 2.0 version of the FreVAX smartphone app could control the FreVAX intramuscular needle-free device. It was developed to improve communication with the FreVAX system, a pig intramuscular needle-free vaccine injection device. Similarly, in November 2021, Felpreva (tigolaner/emodepside/praziquantel), to treat both internal and external parasite infestations for cats, was granted marketing authorization by the European Commission for marketing in Germany.

However, the increasing cost of animal testing and veterinary services is expected to hinder market growth.

Germany Veterinary Healthcare Industry Segmentation

As per the scope of the report, veterinary healthcare comprises the products used in the diagnosis and treatment of diseases in animals. 

The Germany Veterinary Healthcare Market is Segmented by Product (Therapeutics (Vaccines, Parasiticides, Anti-infectives, Medical Feed Additives, and Other Therapeutics) and Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other Diagnostics), and Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals). The report offers value (in USD million) for the above segments.